EP3280392
Skömmtunaráætlanir fyrir amísúlpríð til þess að meðhöndla ógleði og uppköst
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.4.2016EP published:
24.2.2021EP application number:
16716659.4
EP translation filed:
14.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
10.4.2036Expiry date:
10.4.2026Next due date:
30.4.2026
Title:
DOSAGE REGIMENS OF AMISULPRIDE FOR TREATING NAUSEA AND VOMITING
Timeline
Today
11.4.2016EP application
24.2.2021EP Publication
14.4.2021Translation submitted
15.5.2021Registration published
10.4.2026Expires
Owner
Name:
Acacia Pharma LimitedAddress:
The Officers' Mess Royston Road, Duxford Cambridge CB22 4QH, GB
Inventor
Name:
GILBERT, Julian CliveAddress:
Harston Cambridgeshire GB22 7GG, GB
Name:
GRISTWOOD, Robert WilliamAddress:
Harston Cambridgeshire GB22 7GG, GB
Name:
FOX, GabrielAddress:
Harston Cambridgeshire GB22 7GG, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201506116Date:
10.4.2015Country:
GB
Classification
Categories:
A61K 9/00, A61K 31/40, A61K 31/4178, A61K 31/439, A61K 31/454, A61K 31/473, A61K 31/496, A61K 31/5377, A61K 31/573, A61P 1/08, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 30.4.2021
Expires: 10.4.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 22.4.2022
Expires: 10.4.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.4.2023
Expires: 10.4.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 19.3.2024
Expires: 10.4.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 14.4.2025
Expires: 10.4.2026
Payer: Árnason Faktor ehf.